Melek Denizli - VHIR Research Institute

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 9 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

195P Preclinical Efficacy of the Trastuzumab Duocarmazine SYD985 As Monotherapy or in Combination with the PARP Inhibitor Niraparib in HER2-expressing Endometrial Cancer

E. Colas,C.P. Moiola, C. Lopez Gil,M. Rebull,M. Denizli, A. Sotoca Covaleda,V. Bebia Conesa, L. Salazar, S. Cabrera, M. van der Vleuten, P. Groothuis,A. Gil-Moreno

Annals of Oncology (2024)

Cited0Views0Bibtex

547 Preclinical efficacy of the trastuzumab duocarmazine SYD985 as monotherapy or in combination with the PARP inhibitor niraparib in HER2-expressing endometrial cancer

Cristian Pablo Moiola,Carlos Lopez-Gil,Marta Rebull,Melek Denizli, Ana Sotoca-Covaleda,Vicente Bebia, Lourdes Salazar,Silvia Cabrera,Monique Van Der Vleuten,Patrick Groothuis,Antonio Gil-Moreno,Eva Colas

Poster and E-Posters (2024)

Cited0Views0Bibtex

1046 Unveiling the Impact of Intra-Tumor Heterogeneity on Treatment Response to Achieve Precision Medicine for Endometrial Cancer Patients

Beatriz Villafranca-Magdalena,Cristian P. Moiola, Olga Charles,Melek Denizli,Marta Rebull,Genı́s Parra, Josep Castellví,Vicente Bebia, Silvia Cabrera,Antonio Gil‐Moreno,Eva Colás

openalex（2024）

Cited0Views0Bibtex

564 Molecular Profile May Preoperatively Predict Extrauterine Spread in Endometrial Cancer Patients: a Retrospective Analysis

Vicente Bebia,Carlos Lopez-Gil, Ana Luzarraga-Aznar,Melek Denizli,Lourdes Salazar-Huayna,Nihed Abdessayed,Josep Castellví, Elvira Vallés,Eva Colás,Antonio Gil-Moreno,Silvia Cabrera

Poster and E-Posters (2024)

Cited0Views0Bibtex

211P GynePDX: A New Platform of Preclinical Models for Endometrial and Ovarian Cancers

M. Denizli, B. Villafranca Magdalena, I. de la Calle Fuentes,M. Rebull, C. Masferrer-Ferragutcasas, F. Serra, L. Salazar, A. Luzarraga Aznar, S. Cabrera,A. Gil-Moreno, E. Colas

Annals of Oncology (2024)

Cited0Views0Bibtex

Molecular Classification Improves Preoperative Risk Assessment of Endometrial Cancer

Silvia Cabrera,Vicente Bebia,Carlos Lopez-Gil,Ana Luzarraga-Aznar,Melek Denizli,Lourdes Salazar-Huayna,Nihed Abdessayed,Josep Castellvi,Eva Colas,Antonio Gil-Moreno

Gynecologic Oncology (2024): 56-63

Cited0Views0WOSBibtex

1062 GynePDX: a new platform of preclinical models for endometrial and ovarian cancers

Beatriz Villafranca-Magdalena,Melek Denizli, Irene De La Calle,Marta Rebull, Carina Masferrer-Ferragutcasas,Carlos Lopez-Gil, Francesc Serra,Cristian Pablo Moiola, Lourdes Salazar,Ana Luzarraga,Silvia Cabrera,Antonio Gil-Moreno,Eva Colas

Poster and E-Posters (2024)

Cited0Views0Bibtex

6P Unveiling the Impact of Intra-Tumor Heterogeneity in Treatment Response to Achieve Personalized Medicine for Endometrial Cancer Patients

B. Villafranca Magdalena,M. Denizli, C. Masferrer-Ferragutcasas,M. Rebull,G. Parra,Á. García,S. Cabrera,A. Gil-Moreno,C.P. Moiola,E. Colas

ESMO Openno. 1 (2023): 100860

Cited0Views0Bibtex

MAP Kinase ERK5 Modulates Cancer Cell Sensitivity to Extrinsic Apoptosis Induced by Death-Receptor Agonists

Sergio Espinosa-Gil,Saska Ivanova,Elisenda Alari-Pahissa,Melek Denizli,Beatriz Villafranca-Magdalena,Maria Viñas-Casas,Idoia Bolinaga-Ayala,Andrés Gámez-García, Claudia Faundez-Vidiella,Eva Colas,Miguel Lopez-Botet,Antonio Zorzano,José Miguel Lizcano

Cell death and diseaseno. 11 (2023)

Cited0Views0WOSNATUREBibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn